AP2011005728A0 - Pyrrolidines. - Google Patents

Pyrrolidines.

Info

Publication number
AP2011005728A0
AP2011005728A0 AP2011005728A AP2011005728A AP2011005728A0 AP 2011005728 A0 AP2011005728 A0 AP 2011005728A0 AP 2011005728 A AP2011005728 A AP 2011005728A AP 2011005728 A AP2011005728 A AP 2011005728A AP 2011005728 A0 AP2011005728 A0 AP 2011005728A0
Authority
AP
ARIPO
Prior art keywords
pyrrolidines
Prior art date
Application number
AP2011005728A
Other languages
English (en)
Inventor
James Edward John Mills
Sarah Elizabeth Skerratt
Kevin Neil Dack
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP2011005728A0 publication Critical patent/AP2011005728A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2011005728A 2008-11-10 2009-10-30 Pyrrolidines. AP2011005728A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11286908P 2008-11-10 2008-11-10
PCT/IB2009/054824 WO2010052625A1 (en) 2008-11-10 2009-10-30 Pyrrolidines

Publications (1)

Publication Number Publication Date
AP2011005728A0 true AP2011005728A0 (en) 2011-06-30

Family

ID=41503565

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005728A AP2011005728A0 (en) 2008-11-10 2009-10-30 Pyrrolidines.

Country Status (31)

Country Link
US (1) US8278343B2 (enExample)
EP (1) EP2364296A1 (enExample)
JP (1) JP2012508225A (enExample)
KR (1) KR20110083733A (enExample)
CN (1) CN102209710A (enExample)
AP (1) AP2011005728A0 (enExample)
AR (1) AR074314A1 (enExample)
AU (1) AU2009312427B2 (enExample)
BR (1) BRPI0920924A2 (enExample)
CA (1) CA2741589A1 (enExample)
CL (1) CL2011001034A1 (enExample)
CO (1) CO6382112A2 (enExample)
CR (1) CR20110217A (enExample)
CU (1) CU20110093A7 (enExample)
DO (1) DOP2011000127A (enExample)
EA (1) EA201100549A1 (enExample)
EC (1) ECSP11011032A (enExample)
GE (1) GEP20125607B (enExample)
IL (1) IL212490A0 (enExample)
MA (1) MA32782B1 (enExample)
MX (1) MX2011004903A (enExample)
NI (1) NI201100092A (enExample)
NZ (1) NZ592311A (enExample)
PA (1) PA8848001A1 (enExample)
PE (1) PE20110663A1 (enExample)
SV (1) SV2011003896A (enExample)
TN (1) TN2011000211A1 (enExample)
TW (1) TW201022234A (enExample)
UY (1) UY32228A (enExample)
WO (1) WO2010052625A1 (enExample)
ZA (1) ZA201104310B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) * 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
TW201326154A (zh) 2011-11-28 2013-07-01 拜耳知識產權公司 作為ep2受體拮抗劑之新穎2h-吲唑
JPWO2013176220A1 (ja) * 2012-05-25 2016-01-14 国立大学法人京都大学 概日リズム調整
CN110041269A (zh) * 2019-05-16 2019-07-23 海门瑞一医药科技有限公司 一种2-氯-5-羟基嘧啶的制备方法
JP2024524986A (ja) 2021-06-24 2024-07-09 レザボア ニューロサイエンス,インコーポレイテッド Ep2アンタゴニスト化合物
EP4359399A4 (en) * 2021-06-24 2025-04-23 Reservoir Neuroscience, Inc. EP2 antagonist compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU646722B2 (en) * 1991-01-21 1994-03-03 Shionogi Seiyaku Kabushiki Kaisha 3-benzylidene-1-carbamoyl-2-pyrrolidone analog
AU2002358772B2 (en) * 2001-12-20 2008-11-20 Merck Serono Sa Pyrrolidine derivatives as prostaglandin modulators
US8039507B2 (en) * 2005-06-29 2011-10-18 Allergan, Inc. Therapeutic substituted gamma lactams
US7592364B2 (en) * 2006-02-28 2009-09-22 Allergan, Inc. Substituted gamma lactams as therapeutic agents
US7550448B2 (en) * 2006-05-24 2009-06-23 Allergan, Inc. Therapeutic compounds
DE102006039912A1 (de) * 2006-08-25 2008-03-20 Bayer Healthcare Ag Substituierte Spirotetronsäuren und ihre Verwendung
AU2008249744A1 (en) * 2007-05-10 2008-11-20 Pfizer Limited Azetidine derivatives and their use as prostaglandin E2 antagonists

Also Published As

Publication number Publication date
TW201022234A (en) 2010-06-16
PE20110663A1 (es) 2011-09-23
US8278343B2 (en) 2012-10-02
DOP2011000127A (es) 2011-07-15
ECSP11011032A (es) 2011-06-30
PA8848001A1 (es) 2010-06-28
CN102209710A (zh) 2011-10-05
EA201100549A1 (ru) 2011-12-30
UY32228A (es) 2010-06-30
ZA201104310B (en) 2012-02-29
SV2011003896A (es) 2011-07-05
US20100120793A1 (en) 2010-05-13
GEP20125607B (en) 2012-08-10
EP2364296A1 (en) 2011-09-14
AU2009312427B2 (en) 2011-10-20
CL2011001034A1 (es) 2011-11-11
AU2009312427A1 (en) 2010-05-14
JP2012508225A (ja) 2012-04-05
BRPI0920924A2 (pt) 2016-10-04
MA32782B1 (fr) 2011-11-01
AR074314A1 (es) 2011-01-05
MX2011004903A (es) 2011-05-30
IL212490A0 (en) 2011-06-30
WO2010052625A1 (en) 2010-05-14
CU20110093A7 (es) 2012-01-31
CR20110217A (es) 2011-05-12
CA2741589A1 (en) 2010-05-14
NI201100092A (es) 2011-10-31
KR20110083733A (ko) 2011-07-20
NZ592311A (en) 2012-12-21
TN2011000211A1 (fr) 2012-12-17
CO6382112A2 (es) 2012-02-15

Similar Documents

Publication Publication Date Title
SI2384326T1 (sl) Pirolo(2,3-d)pirimidinske spojine
EP2280616A4 (en) BODY FOR BABY
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
EP2233305A4 (en) GRAPHIC PRINTER
GB0815068D0 (en) Insectical combinations
ZA201104310B (en) Pyrrolidines
EP2346675A4 (en) HURRY
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
GB0808831D0 (en) .
GB0811138D0 (en) .
GB0810164D0 (en) Wedge-dek, shower-floor gradient-former
AU3972P (en) Tobruk xTriticosecale
AU3935P (en) DPV308 Dianella prunina
AU3977P (en) PARV01 Myoporum parvifolium
AU4098P (en) NPW2 Dianella tasmanica
GB0813189D0 (en) M.l.d
IL188627A0 (en) Classified-lahaim.com
GB0801773D0 (en) I.f.d.d
GB0805811D0 (en) S.t.e.p.
GB0805810D0 (en) S.t.e.p.
GB0821840D0 (en) Combinations
GB0701035D0 (en) .
GB0701036D0 (en) .